IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 10,930
-120 (-1.09%)
Dec 10, 2025, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 154.9 billion as of December 10, 2025. Its market cap has decreased by -13.06% in one year.
Market Cap
154.90B
Enterprise Value
132.05B
Revenue
4.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,930.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 154.90B, a decrease of -69.25%. That is a compound annual growth rate of -50.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 154.90B | 3.76% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.41T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.44T |
| Yuhan | 8.66T |
| LigaChem Biosciences | 6.75T |
| HLB Co., Ltd. | 6.53T |